These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27012660)

  • 21. Does multilingualism act as a protective factor (cognitive reserve) against cognitive impairment in multiple sclerosis?: A retrospective cohort study.
    Morrow SA; Balusha AAK; Rosehart H; Casserly C; Racosta JM
    Mult Scler Relat Disord; 2023 Dec; 80():105060. PubMed ID: 37866025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool.
    Yoshii F; Takagi S; Nagata E; Hasegawa Y; Kunika N; Maki F; Mochizuki H; Ogino M; Kuroiwa Y
    J Neurol Sci; 2015 Dec; 359(1-2):323-7. PubMed ID: 26671136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual-cognitive processing deficits in pediatric multiple sclerosis.
    Smerbeck AM; Parrish J; Serafin D; Yeh EA; Weinstock-Guttman B; Hoogs M; Krupp LB; Benedict RH
    Mult Scler; 2011 Apr; 17(4):449-56. PubMed ID: 21343232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Processing speed test: Validation of a self-administered, iPad
    Rao SM; Losinski G; Mourany L; Schindler D; Mamone B; Reece C; Kemeny D; Narayanan S; Miller DM; Bethoux F; Bermel RA; Rudick R; Alberts J
    Mult Scler; 2017 Dec; 23(14):1929-1937. PubMed ID: 28080262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The computer-based Symbol Digit Modalities Test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients.
    Bigi S; Marrie RA; Till C; Yeh EA; Akbar N; Feinstein A; Banwell BL
    Neurol Sci; 2017 Apr; 38(4):635-642. PubMed ID: 28078569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced information processing speed as primum movens for cognitive decline in MS.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Mult Scler; 2015 Jan; 21(1):83-91. PubMed ID: 25013149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
    Gromisch ES; Zemon V; Holtzer R; Chiaravalloti ND; DeLuca J; Beier M; Farrell E; Snyder S; Schairer LC; Glukhovsky L; Botvinick J; Sloan J; Picone MA; Kim S; Foley FW
    Clin Neuropsychol; 2016 Oct; 30(7):1032-49. PubMed ID: 27279357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
    Lapshin H; Lanctôt KL; O'Connor P; Feinstein A
    Mult Scler; 2013 Dec; 19(14):1905-12. PubMed ID: 23652217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study.
    Filser M; Schreiber H; Pöttgen J; Ullrich S; Lang M; Penner IK
    J Neurol; 2018 Nov; 265(11):2587-2593. PubMed ID: 30171410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symbol digit modalities test predicts decline of off-road driving ability in Japanese patients with multiple sclerosis.
    Maeta M; Mizuno M; Okubo S; Ogasawara M; Terauchi T; Suzuki M; Akasaka H; Sato Y; Ohi K; Maeda T
    Mult Scler Relat Disord; 2022 Dec; 68():104150. PubMed ID: 36055114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive mediated eye movements during the SDMT reveal the challenges with processing speed faced by people with MS.
    Pavisian B; Patel VP; Feinstein A
    BMC Neurol; 2019 Dec; 19(1):340. PubMed ID: 31878918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
    Dusankova JB; Kalincik T; Havrdova E; Benedict RH
    Clin Neuropsychol; 2012; 26(7):1186-200. PubMed ID: 23034066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain activation patterns and cognitive processing speed in patients with pediatric-onset multiple sclerosis.
    Akbar N; Banwell B; Sled JG; Binns MA; Doesburg SM; Rypma B; Lysenko M; Till C
    J Clin Exp Neuropsychol; 2016; 38(4):393-403. PubMed ID: 26695705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the French version of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).
    Maubeuge N; Deloire MSA; Brochet B; Ehrlé N; Charré-Morin J; Saubusse A; Ruet A;
    Mult Scler Relat Disord; 2021 Feb; 48():102692. PubMed ID: 33352358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance.
    Sandry J; Simonet DV; Brandstadter R; Krieger S; Katz Sand I; Graney RA; Buchanan AV; Lall S; Sumowski JF
    Mult Scler Relat Disord; 2021 Jun; 51():102950. PubMed ID: 33887609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
    Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
    Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tunisian version of the brief international cognitive assessment for multiple sclerosis: Validation and normative values.
    Souissi A; Mrabet S; Ferchichi W; Gharbi A; Nasri A; Djebara MB; Kacem I; Gouider R
    Mult Scler Relat Disord; 2022 Feb; 58():103444. PubMed ID: 34929452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trail Making Test Could Predict Impairment in Cognitive Domains in Patients with Multiple Sclerosis: A Study of Diagnostic Accuracy.
    Kabiri S; Jameie M; Balali P; Adib Moradi S; Sanjari Moghaddam H; Aghamollaii V; Harirchian MH
    Arch Clin Neuropsychol; 2023 Jan; 38(1):37-48. PubMed ID: 35901460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual and motor confounds on the symbol digit modalities test.
    Chen MH; Chiaravalloti ND; Genova HM; Costa SL
    Mult Scler Relat Disord; 2020 Oct; 45():102436. PubMed ID: 32750607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.